NIH-funded research R37 grant

AI-assisted radiosurgery planning for multiple brain metastases

Official title: Artificial Intelligence Driven Automatic Treatment Planning of Stereotactic Radiosurgery for the Management of Multiple Brain Metastases

Funded at University of Chicago · NIH-11175332 · Data updated 2026-11-12

This project uses artificial intelligence to create faster, personalized radiosurgery plans for people with multiple brain metastases.

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startSeptember 1, 2022
Project endAugust 31, 2027
Funding year2025
Award (this year)$357,794
NIH project number5R37CA272755-04
Project IDNIH-11175332 on NIH RePORTER

Who could benefit from this research

Could help

People with multiple (typically four or more) brain metastases who are being considered for stereotactic radiosurgery would be the ideal candidates.

Less likely to help

Patients whose disease requires whole-brain radiotherapy, who have diffuse leptomeningeal spread, or whose tumors are unsuitable for SRS are unlikely to benefit from this planning approach.

What this research studies

This project will use AI to automatically generate stereotactic radiosurgery (SRS) plans for patients who have many brain metastases. The AI learns from past plans and physician preferences to produce high-quality, consistent plans even when there are many tumors of different sizes and locations. That could shorten planning time and make SRS more practical as an alternative to whole-brain radiation. The team will compare AI-generated plans to conventional planning using clinical data and physician review.

Why it matters

Potential benefit: If successful, this could give patients with multiple brain tumors quicker, more personalized SRS plans that may help preserve thinking and memory compared with whole-brain radiation.

How similar studies have gone: SRS for multiple brain metastases has shown promising clinical results recently, but using AI to fully automate high-quality treatment planning is a newer approach still under testing.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Tian, Zhen — University of Chicago
  • Study coordinator: Tian, Zhen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.